Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
5JUL

Uganda Ebola cases jump from 2 to 9

3 min read
10:12UTC

Uganda's confirmed Bundibugyo cases rose from 2 to 9 in DON605, all in Kampala and neighbouring Wakiso. A country this good at case-finding moving in that direction signals onward transmission, not a single traveller.

ScienceDeveloping
Key takeaway

Uganda's confirmed cases rose from 2 to 9 in Kampala and Wakiso, signalling genuine onward transmission across the border.

Uganda's confirmed Bundibugyo Ebola cases rose from 2 to 9 in WHO bulletin DON605 on 29 May, all in the capital Kampala and the neighbouring district of Wakiso 1. The Kampala index case had been imported from DRC three weeks earlier ; nine cases now means onward transmission inside Uganda, not a single returning traveller.

That movement matters more than the raw DRC totals. Uganda has strong surveillance and a track record: in 2022 it contained a Sudan ebolavirus outbreak of 142 confirmed cases in 113 days without any licensed vaccine. A health system that effective at case-finding does not move from 2 to 9 as a testing artefact.

WHO Director-General Tedros Adhanom Ghebreyesus said on Monday 25 May that the outbreak was "outpacing us" 2. The cross-border spread forces a second national response axis, splitting scarce trained-responder capacity across two countries at once. Uganda contained its last Ebola outbreak with a functioning state health authority able to compel and protect contacts; whether it holds these nine cases as tightly is the test now running.

Deep Analysis

In plain English

Uganda is a country that shares a long border with DRC, where the Ebola outbreak is centred. A person who had been in DRC travelled to Kampala, Uganda's capital, and later tested positive for Ebola. That person has now passed the virus to at least eight more people in Kampala and the surrounding Wakiso district. This matters for two reasons. First, Kampala is a city of more than two million people, which makes tracing and isolating everyone who may have been exposed much harder than in a rural area. Second, Uganda had previously managed to stop an Ebola outbreak in 2022 without a vaccine, by rapidly finding and isolating every contact. Health authorities are now trying to do the same thing again, but for a different Ebola strain with no approved treatment at all.

Deep Analysis
Root Causes

Uganda shares an ~877-kilometre land border with DRC, with the most active crossing at Bwera-Kasindi directly adjacent to the outbreak's Ituri epicentre.

Cross-border movement for gold mining, trade, and healthcare-seeking is not captured by formal border surveillance: the WHO PHEIC technical assessment noted on 17 May that the outbreak had been circulating for at least four weeks before detection, meaning DRC-Uganda population movement during that undetected period brought infected individuals to Kampala before any exit screening was in place.

A second structural cause is the absence of a licensed Bundibugyo treatment that Uganda could use for ring prophylaxis or trial dosing. In the 2022 Sudan ebolavirus response, Uganda had access to a candidate vaccine (the Sabin Institute's ChAdOx Sudan candidate, under emergency protocol) and could offer enrolled contacts an intervention beyond surveillance alone. No comparable option exists for Bundibugyo as of 29 May.

What could happen next?
  • Risk

    Kampala's two-million-person population and high referral-hospital utilisation rate create conditions for healthcare-associated amplification if isolation protocols are not applied early to all confirmed contacts.

  • Precedent

    If Uganda contains the Kampala cluster using contact-tracing alone, it will become the first documented example of urban Bundibugyo containment without countermeasures, informing WHO protocols for future non-Zaire Ebola introductions in capital cities.

First Reported In

Update #5 · Ebola money arrives, the cure does not

World Health Organization· 2 Jun 2026
Read original
Different Perspectives
Germany (evacuation recipient)
Germany (evacuation recipient)
Germany received the Bundibugyo outbreak's third international medical evacuation on 13 July, a US humanitarian worker infected in Bunia on 10 July. The evacuation, following a French doctor's 24 June departure and May's first US case, tests whether isolation and biocontainment protocols scale beyond DR Congo's own borders.
Pennsylvania Department of Public Health
Pennsylvania Department of Public Health
PDPH retested and retracted a false-positive measles wastewater signal on 6 July, then confirmed and publicised a real airport exposure from 4 July, with commissioner Palak Raval-Nelson stressing there is no broad threat to the general public. The national count, 2,231 cases across 42 states by 9 July, is on pace to beat 2025's 2,289-case record before September.
World Health Organization
World Health Organization
WHO published its first dedicated Blueprint on fungal disease and antifungal resistance on 1 July, estimating more than 300 million people suffer serious fungal disease annually. The Blueprint names the gap in WHO's own AMR strategy rather than waiting for an external audit to force the admission.
Africa CDC
Africa CDC
Africa CDC issued a formal 11 July appeal for responder protection, training and psychosocial support after health-worker infections tripled from 34 to 112 in a month. The appeal repeats June's unmet call for a rapid Bundibugyo diagnostic test, showing the ask has shifted from tools to basic safety and pay.
Front-line health workers, Ituri Province
Front-line health workers, Ituri Province
Health workers in Ituri Province walked off the job or threatened to strike over unpaid hazard pay and delayed salaries, even as responder infections tripled to 112 with 35 dead. Their absence narrows the isolation workforce the CDC's model says must reach 70% coverage to avoid a 20,000-case worst case.
ECDC
ECDC
ECDC co-published the isolation and contact-tracing figures behind WHO's DON612, tracking Ituri's isolation rate rising from 35 to 44 percent while still rating EU/EEA import risk as very low. Brussels backs the WHO line against travel restrictions, the position France's own contact-tracing response, not the US entry ban, actually validated.